Scientists track pregnancy outcomes after new virus vaccine
NCT ID NCT07414524
Summary
This study aims to understand the safety of a chikungunya virus vaccine for pregnant women and their babies. Researchers will observe 200 women in Brazil who received the vaccine during or just before pregnancy, comparing their health outcomes to women who received other routine pregnancy vaccines. The study will collect information on pregnancy results and infant health up to 12 weeks after birth without changing anyone's standard medical care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIKUNGUNYA VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.